|
|
Sponsored Symposia
|
Thursday, September 25, 2008 |
| 12:30-14:00 |
Otsuka Sponsored Symposium - New Approaches for Ischemic Brain Infarcts
Convenors: Yukito Shinohara, Japan
Michael G. Hennerici, Germany
Cilostazol, Adenosine, and Protection in Ischemia/Reperfusion Injury
Yongge Liu, USA
Effects of Cilostazol in Patients with Intracranial and Extracranial Atherothrombotic Diseases
Shinichiro Uchiyama, Japan
Cilostazol as a Guardian Against Ischemic Microvascular Damages
Makoto Suematsu, Japan
Antithrombotic Therapy in Acute Ischemic Stroke
Yong-Seok Lee, South Korea
Ebewe Sponsored Symposium - Cerebral Neuroprotection, Rescue and Recovery - The Role of Cerebrolysin
Convenors: Michael Brainin, Austria
Wolf-Dieter Heiss, Germany
Cerebral Reorganisation after Stroke
Rüdiger Seitz, Germany
Continuity between neuroprotection, neuroplasticity and brain recovery
Dafin Muresanu, Romania
Recovery drugs and study endpoints
Natan Bornstein, Israel
A neurotrophic treatment option supports stroke recovery
Christian Stadler, Germany |
| 17:45-18:55 |
Otsuka Satellite Symposium
Virchow's Triads 2008 -The Next Target for Antithrombotic Therapy
Convenors: Louis R. Caplan, USA
Takenori Yamaguchi, Japan
Vascular Targets for Treatment in Evolving Cerebral Ischemia and Virchow‘s Triad
Gregory J. del Zoppo, USA
Microvascular Actions of Cilostazol Analyzed by Systems Biological Approaches
Makoto Suematsu, Japan
Why Were there Unexpected Results of Large Cinical Trials: A Perspective in Relation to Virchow's Triad
Louis R. Caplan, USA
|
| 17:45-19:15 |
sanofi-aventis Satellite Symposium
New Insights in Atrial Fibrillation and Cardio-embolic Stroke
Convenors: Werner Hacke, Germany
Stefan H. Hohnloser, Germany
Current Management of Cardio-embolic Stroke: The Neurologist's Perspective
Ralph Sacco, USA
How Can We Best Prevent Cardio-embolic Stroke: The Cardiologist's Perspective
Ariel Cohen, France
New Approaches in Managing At-Risk Patients With Atrial Fibrillation
Stefan H. Hohnloser, Germany |
Friday, September 26, 2008 |
| 12:30-14:00 |
Boehringer Ingelheim - Path Breaking Results in Ischaemic Stroke Therapy
Convenors: Werner Hacke, Germany
Louis R. Caplan, USA
Widening The Time Window for I.V. Thrombolysis: The Main Results of ECASS3
Werner, Hacke, Germany
Safety Results of ECASS III
Kennedy Lees, UK
Further Secondary Analysis
Danilo Toni, Italy
Widening The time Window for I.V. Thrombolysis: MRI-based selection
Geoffrey Donnan, Australia
General Discussion
|
| |
sanofi-aventis/Bristol-Myers Squibb Satellite Symposium
Changing Landscapes in Stroke Management
Convenor: Mark Alberts, USA
Alastair Buchan, UK
Introduction
Mark Alberts, USA / Alastair Buchan, UK
REACHing New Frontiers in Stroke Management
Mark Alberts, USA
Antiplatelet Therapy in Stroke
Alastair Buchan, UK
Unanswered Questions in Stroke Management
Oscar Benavente, USA
What Should Change in Stroke Management and Guidelines
Stephen Davis, Australia
Conclusion and Q&A Session
Mark Alberts, USA / Alastair Buchan, UK | |
|
|
|
|